Literature DB >> 3179187

Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).

M C Bibby1, J A Double, P M Loadman.   

Abstract

MAC 16 is one of a series of mouse colon tumours originally induced by dimethylhydrazine. It is a relatively slow growing subcutaneous adenocarcinoma which becomes necrotic as it grows and causes severe body wasting in the host. This study has indicated that the tumour is resistant to a large number of standard anti-cancer drugs but is highly responsive to the investigational agent flavone acetic acid (FAA). The levels of FAA achieved in tumours are lower than those necessary for activity in vitro suggesting its mechanism of action in vivo is not direct cytotoxicity. Responding tumours demonstrate massive tissue necrosis and those which are not cured have viable tumour cells associated with tumour blood vessels. The anti-tumour effects are accompanied by control of the host's cancer cachexia. The unique chemosensitivity of MAC 16 to FAA suggests that this agent has a novel mechanism which may be dependent upon specific biological characteristics of tumours.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179187      PMCID: PMC2246591          DOI: 10.1038/bjc.1988.215

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours.

Authors:  G P Smith; S B Calveley; M J Smith; B C Baguley
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

2.  Transplantation of adenocarcinomas of the colon in mice.

Authors:  J A Double; C R Ball; P N Cowen
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

3.  In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015).

Authors:  W A Schroyens; P F Dodion; C Sanders; M Loos; N E Dethier; A R Delforge; P A Stryckmans; Y Kenis
Journal:  Eur J Cancer Clin Oncol       Date:  1987-08

4.  Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent.

Authors:  L S Capolongo; G Balconi; P Ubezio; R Giavazzi; G Taraboletti; A Regonesi; O C Yoder; M D'Incalci
Journal:  Eur J Cancer Clin Oncol       Date:  1987-10

5.  Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.

Authors:  M C Bibby; J A Double; S A Ali; K C Fearon; R A Brennan; M J Tisdale
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

6.  Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.

Authors:  J Plowman; V L Narayanan; D Dykes; E Szarvasi; P Briet; O C Yoder; K D Paull
Journal:  Cancer Treat Rep       Date:  1986-05

7.  Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).

Authors:  D J Kerr; S B Kaye; J Graham; J Cassidy; M Harding; A Setanoians; J C McGrath; W R Vezin; D Cunningham; G Forrest
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

8.  Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.

Authors:  J A Double; M C Bibby; P M Loadman
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

9.  Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer.

Authors:  P Haase; D M Cowen; J C Knowles; E H Cooper
Journal:  Br J Cancer       Date:  1973-12       Impact factor: 7.640

10.  Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).

Authors:  M C Bibby; J A Double; R M Phillips; P M Loadman
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

View more
  7 in total

1.  Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.

Authors:  Minh Hien Pham; Hervé Rhinn; Nicolas Auzeil; Anne Regazzetti; Djamel Eddine Harami; Daniel Scherman; Guy G Chabot
Journal:  Drug Metab Lett       Date:  2011-04

2.  Flavone acetic acid distribution in human malignant tumors.

Authors:  G Damia; A Freschi; R Sorio; A Braida; G Caruso; M Quaia; S Monfardini; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.

Authors:  M C Bibby; R M Phillips; J A Double
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

4.  Divergent effects of flavone acetic acid on established versus developing tumour blood flow.

Authors:  V Mahadevan; I R Hart
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

5.  Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.

Authors:  L H Patterson; S R McKeown; K Ruparelia; J A Double; M C Bibby; S Cole; I J Stratford
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

6.  Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data.

Authors:  T S Maughan; R Ward; I Dennis; D J Honess; P Workman; N M Bleehen
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

7.  Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.

Authors:  M C Bibby; R M Phillips; J A Double; G Pratesi
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.